|
Characteristics
|
AD
|
CN
|
p-value
|
Test
|
|---|
| |
(N = 40)
|
(N = 38)
| | |
|---|
|
Mean Age +/- SD
|
69.0 +/- 9.1
|
69.5 +/- 9.7
|
0.825
|
T
|
|
Mean Years of Education +/- SD
|
14.8 +/- 3.6
|
16.6 +/- 3.0
|
0.015
|
T
|
|
Mean MMSE +/- SD
|
19.9 +/- 7.7
|
29.2 +/- 1.3
|
1.0E-9
|
T
|
|
% Male
|
25.0
|
34.21
|
0.459
|
F
|
|
% Caucasian
|
82.5
|
86.8
|
1.00
|
F
|
|
% Taking Antidepressant
|
30.0
|
21.05
|
0.441
|
F
|
|
% Taking Antipsychotic
|
5.0
|
0.0
|
0.494
|
F
|
|
% Taking Anxioytic
|
12.5
|
13.2
|
1.00
|
F
|
|
% Taking Corticosteroids
|
2.5
|
13.2
|
0.104
|
F
|
|
% Taking Cholinesterase Inhibitor
|
37.5
|
0.0
|
<1.0E-9
|
F
|
|
% Taking Memantine
|
15.0
|
0.0
|
0.026
|
F
|
|
% Taking Statins
|
20.0
|
26.3
|
0.595
|
F
|
- Abbreviations: AD Alzheimer’s disease, CN Normal cognition, SD Standard Deviation, T two-sample t test, two-sided, MMSE Mini-Mental State Exam obtained at date closest to sample if not available concurrently, F Fisher’s exact test, two-sided.
